Menu

Markets

Research

News

Learn
Paper trading
AI Chat
WatchlistsPortfoliosAlerts
Sign in

LGNZZ

Ligand Pharmaceuticals Incorporated

USD

Set alert

Price alert · LGNZZ

All alert types
0.07 USD 0.00 0.00%
As of Oct 19, 2026
0.065 Day range 0.065
0.065 52-week range 0.17
YTD
0.00%
1 year
0.00%
Open
0.065
Prev close
0.065
Mkt cap
1.40M
Vol
150
Avg vol
50.00K
EPS
0.00
P/E
0.00
More statistics
Low
0.065
High
0.065

5D chart

Chart tools
Interval
1m5m15m30m

Chart is warming up

The five-day price history for LGNZZ has not been loaded yet. Try again in a moment.

Financial health

Altman Z-Score

0.58 Distress zone

Bankruptcy-risk model: below 1.81 distress, above 2.99 safe.

Piotroski F-Score

5 / 9 Average

Nine pass/fail tests of profitability, leverage and efficiency.

Valuation

P/E 0.0×
FY 2016: -0.1×FY 2017: 0.0×FY 2018: 0.0×FY 2019: 0.0×FY 2020: -0.8×FY 2021: 0.0×FY 2022: -0.1×FY 2023: 0.0×FY 2024: 0.3×FY 2025: 0.0×
FY 2016 5y median 0.0× FY 2025
P/S 0.0×
FY 2016: 0.0×FY 2017: 0.0×FY 2018: 0.0×FY 2019: 0.0×FY 2020: 0.0×FY 2021: 0.0×FY 2022: 0.0×FY 2023: 0.0×FY 2024: 0.0×FY 2025: 0.0×
FY 2016 5y median 0.0× FY 2025
P/B 0.0×
FY 2016: 0.0×FY 2017: 0.0×FY 2018: 0.0×FY 2019: 0.0×FY 2020: 0.0×FY 2021: 0.0×FY 2022: 0.0×FY 2023: 0.0×FY 2024: 0.0×FY 2025: 0.0×
FY 2016 5y median 0.0× FY 2025
P/FCF 0.0×
FY 2016: 0.0×FY 2017: 0.0×FY 2018: 0.0×FY 2019: -0.1×FY 2020: 0.0×FY 2021: 0.0×FY 2022: 0.0×FY 2023: -0.4×FY 2024: 0.0×FY 2025: 0.0×
FY 2016 5y median 0.0× FY 2025
EV/EBITDA -1.4×
FY 2016: 7.1×FY 2017: 2.8×FY 2018: 2.9×FY 2019: 0.7×FY 2020: 9.2×FY 2021: 2.3×FY 2022: 0.6×FY 2023: -0.1×FY 2024: -1.5×FY 2025: -1.4×
FY 2016 5y median -0.1× FY 2025
EV/Sales -1.0×
FY 2016: 2.1×FY 2017: 1.6×FY 2018: 2.1×FY 2019: 4.8×FY 2020: 2.2×FY 2021: 1.3×FY 2022: 0.2×FY 2023: -0.1×FY 2024: -0.4×FY 2025: -1.0×
FY 2016 5y median -0.1× FY 2025
FCF Yield 3327.7%
FY 2016: 14660.0%FY 2017: 33433.3%FY 2018: 6183.2%FY 2019: -987.5%FY 2020: 2212.3%FY 2021: 3008.2%FY 2022: 5078.4%FY 2023: -232.2%FY 2024: 3929.4%FY 2025: 3327.7%
FY 2016 5y median 3327.7% FY 2025

Profitability

Gross Margin 82.4%
FY 2016: 85.1%FY 2017: 87.6%FY 2018: 91.2%FY 2019: 55.5%FY 2020: 69.9%FY 2021: 60.1%FY 2022: 60.7%FY 2023: 67.0%FY 2024: 72.3%FY 2025: 82.4%
FY 2016 5y median 67.0% FY 2025
Operating Margin 17.6%
FY 2016: 41.2%FY 2017: 48.2%FY 2018: 65.1%FY 2019: -4.8%FY 2020: 4.7%FY 2021: 27.4%FY 2022: 6.5%FY 2023: 7.5%FY 2024: 13.8%FY 2025: 17.6%
FY 2016 5y median 13.8% FY 2025
Net Margin 46.4%
FY 2016: -2.2%FY 2017: 8.9%FY 2018: 57.0%FY 2019: 523.2%FY 2020: -1.6%FY 2021: 23.7%FY 2022: -17.0%FY 2023: 39.7%FY 2024: 5.4%FY 2025: 46.4%
FY 2016 5y median 23.7% FY 2025
ROE 12.2%
FY 2016: -0.7%FY 2017: 3.1%FY 2018: 25.6%FY 2019: 82.0%FY 2020: -0.4%FY 2021: 7.0%FY 2022: -5.6%FY 2023: 7.4%FY 2024: 1.1%FY 2025: 12.2%
FY 2016 5y median 7.0% FY 2025
ROIC 2.4%
FY 2016: -2.3%FY 2017: 2.1%FY 2018: 10.8%FY 2019: -0.3%FY 2020: 0.2%FY 2021: 5.3%FY 2022: -0.3%FY 2023: 1.1%FY 2024: 2.5%FY 2025: 2.4%
FY 2016 5y median 2.4% FY 2025
ROA 8.0%
FY 2016: -0.4%FY 2017: 1.7%FY 2018: 10.9%FY 2019: 42.1%FY 2020: -0.2%FY 2021: 4.4%FY 2022: -4.4%FY 2023: 6.6%FY 2024: 1.0%FY 2025: 8.0%
FY 2016 5y median 4.4% FY 2025

Growth (YoY)

Revenue 60.4%
FY 2016: 51.5%FY 2017: 29.5%FY 2018: 78.2%FY 2019: -52.2%FY 2020: 55.0%FY 2021: 29.6%FY 2022: -18.8%FY 2023: -33.1%FY 2024: 27.3%FY 2025: 60.4%
FY 2016 FY 2025
Operating Income 105.0%
FY 2016: 58.4%FY 2017: 51.6%FY 2018: 140.5%FY 2019: -103.5%FY 2020: 252.6%FY 2021: 658.8%FY 2022: -80.6%FY 2023: -23.5%FY 2024: 134.4%FY 2025: 105.0%
FY 2016 FY 2025
EPS (diluted) 1126.0%
FY 2016: -101.0%FY 2017: 581.8%FY 2018: 1024.5%FY 2019: 434.4%FY 2020: -100.6%FY 2021: 1938.9%FY 2022: -159.8%FY 2023: 248.5%FY 2024: -83.0%FY 2025: 1126.0%
FY 2016 FY 2025
Free Cash Flow -48.6%
FY 2016: 19.6%FY 2017: 110.4%FY 2018: 100.4%FY 2019: -117.4%FY 2020: 257.2%FY 2021: 39.7%FY 2022: 71.2%FY 2023: -104.4%FY 2024: 1923.9%FY 2025: -48.6%
FY 2016 FY 2025

Financial Health

Current Ratio 22.2×
FY 2016: 0.7×FY 2017: 1.0×FY 2018: 10.6×FY 2019: 66.1×FY 2020: 5.0×FY 2021: 11.2×FY 2022: 2.7×FY 2023: 14.1×FY 2024: 8.9×FY 2025: 22.2×
FY 2016 5y median 11.2× FY 2025
Quick Ratio 22.0×
FY 2016: 0.7×FY 2017: 1.0×FY 2018: 10.5×FY 2019: 65.7×FY 2020: 4.7×FY 2021: 10.5×FY 2022: 2.5×FY 2023: 12.7×FY 2024: 8.6×FY 2025: 22.0×
FY 2016 5y median 10.5× FY 2025
Debt / Equity 0.4×
FY 2016: 0.7×FY 2017: 0.6×FY 2018: 1.1×FY 2019: 0.8×FY 2020: 0.6×FY 2021: 0.4×FY 2022: 0.1×FY 2023: 0.0×FY 2024: 0.0×FY 2025: 0.4×
FY 2016 5y median 0.1× FY 2025
Net Debt / EBITDA -1.4×
FY 2016: 7.1×FY 2017: 2.8×FY 2018: 2.9×FY 2019: 0.7×FY 2020: 9.1×FY 2021: 2.3×FY 2022: 0.5×FY 2023: -0.2×FY 2024: -1.5×FY 2025: -1.4×
FY 2016 5y median -0.2× FY 2025
Interest Coverage 10.0×
FY 2016: 3.7×FY 2017: 6.0×FY 2018: 3.4×FY 2019: -0.2×FY 2020: 0.3×FY 2021: 3.4×FY 2022: 7.1×FY 2023: 15.0×FY 2024: 7.6×FY 2025: 10.0×
FY 2016 5y median 7.6× FY 2025

Dividends

Dividend Yield 0.0%
FY 2016: 0.0%FY 2017: 0.0%FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%FY 2025: 0.0%
FY 2016 5y median 0.0% FY 2025
Payout Ratio 0.0%
FY 2016: 0.0%FY 2017: 0.0%FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%FY 2025: 0.0%
FY 2016 5y median 0.0% FY 2025

Annual · latest fiscal year ends 2025-12-31